Shanghai Shyndec Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd., commonly referred to as Shyndec, is a prominent player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong focus on research and development, Shyndec offers a diverse portfolio of products, including generic drugs and innovative formulations. Their commitment to quality and compliance with international standards has positioned them as a trusted partner in the pharmaceutical supply chain. Notable achievements include successful collaborations with global pharmaceutical companies, enhancing their reputation as a reliable source of pharmaceutical solutions.
DitchCarbon Score
How does Shanghai Shyndec Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Shyndec Pharmaceutical Co., Ltd.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shanghai Shyndec Pharmaceutical Co., Ltd.'s reported carbon emissions
Shanghai Shyndec Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Shanghai Shyndec may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Shanghai Shyndec to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai Shyndec Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
